Product/Composition:- | Norfloxacin eye drops |
---|---|
Strength:- | 0.3% |
Form:- | Ophthalmic Drops |
Reference Brands:- | Noroxin(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Norfloxacin eye drops inhibit bacterial DNA gyrase, preventing DNA replication and bacterial growth. They effectively treat bacterial conjunctivitis and ocular infections. Benefits include rapid, targeted relief, broad-spectrum activity, minimal systemic absorption, and safety. They provide effective outpatient treatment for bacterial eye infections with minimal side effects.
Norfloxacin eye drops are approved in the EU and US for treating bacterial conjunctivitis. In the EU, brands and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for norfloxacin eye drops, ensuring adherence to European and US standards for safe, effective ophthalmic antimicrobial therapy.